Picture of Imac Holdings logo

BACK Imac Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+141.75%
3m+51.79%
6m+33.29%
1yr-36%
Volume Change (%)
10d/3m-71.52%
Price vs... (%)
52w High-50.04%
50d MA+48.12%
200d MA+37.91%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-646.63%
Return on Equity-282.84%
Operating Margin-164.47%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Imac Holdings EPS forecast chart

Profile Summary

IMAC Holdings, Inc. owns and manages health and wellness centers that delivers sports medicine, orthopedic care, and restorative joint and tissue therapies for movement restricting pain and neurodegenerative diseases. The Company provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, minimally invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. It operates through two business segments: outpatient medical centers and clinical research division. The Company's research division is conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease. The Company operates approximately 10 outpatient medical clinics in five states in the United States.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    May 23rd, 2018
    Public Since
    February 13th, 2019
    No. of Employees
    85
    Sector
    Healthcare Providers & Services
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    1,138,321

    BACK Share Price Performance

    Upcoming Events for BACK

    Q1 2024 IMAC Holdings Inc Earnings Release

    IMAC Holdings Inc Annual Shareholders Meeting

    Q2 2024 IMAC Holdings Inc Earnings Release

    Similar to BACK

    Picture of ADVANCED BIOMED logo

    ADVANCED BIOMED

    us flag iconNASDAQ Capital Market

    Picture of Akanda logo

    Akanda

    us flag iconNASDAQ Capital Market

    Picture of American Oncology Network logo

    American Oncology Network

    us flag iconNASDAQ Capital Market

    Picture of Assure Holdings logo

    Assure Holdings

    us flag iconNASDAQ Capital Market

    FAQ